Skip to main content
Premium Trial:

Request an Annual Quote

CPGR, UBC Team Up to ID Influenza Biomarkers

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – South Africa's Centre for Proteomic and Genomic Research and researchers from the University of British Columbia are partnering to identify biomarkers that may predict how patients react to vaccinations for seasonal influenza.

CPGR will use its expertise in developing multiplex protein array-based profiling assays and computational solutions for "enhanced" bioinformatics data analysis, CPGR said in a statement. The goal of the project is to create a "biomarker signature assay suitable for companion diagnostic purposes," it added.

Tobias Kollman, assistant professor in the division of infectious and immunological diseases in the department of pediatrics at UBC will lead the university's work on the project. UBC is providing serum samples from a vaccine trial it has been conducting.

Terms of the deal were not disclosed.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.